glp 1 mimetic GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art GLP-1 Supplement for Women &

Clinical trial data shows nausea affects between 15.4% to 43.9% of users depending on dose and formulation, with higher doses producing increased incidence

Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, et al

In other species and contexts, L-carnitine has been discussed in relation to valproic acidassociated toxicity (Gziut T, 2025), which is a reminder that nutrient doesnt automatically mean neutral in complex medical cases

Comparison of direct and network estimates of biological and anthropometric outcomes (A) Total patients (pooled mean difference with 95% CI) cmh-2022-0330-Supplementary-6.pdf Supplementary Material 7